Omega Funds
Venture capital firm · Founded 2004 · Boston, MA · Boston ↗
Omega Funds is a Boston-based venture capital firm founded in 2004 that creates and invests in life sciences companies addressing urgent medical needs. The firm invests across therapeutic areas including oncology, immunology, rare diseases and precision medicine, and has helped bring dozens of products to market.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Omega Funds, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$1.6B
Latest fund
Omega Fund VIII$647M · 2025
Funds
8
Check size
LAST CHECKED NOV 2026
Stages
Pre-seedSeedSeries ASeries B
Sectors
life sciencesbiotechnologydigital healthimmunologyrare diseasesprecision medicine+2
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Scorpion TherapeuticsAcquired
Fierce Biotech's Omega Fund VIII coverage names Scorpion Therapeutics among Omega's recent success stories; Scorpion was acquired by Eli Lilly in a deal potentially worth $2.5B (Jan 2025).
Source: fiercebiotech.com
- EyeBioAcquired
Fierce Biotech's Omega Fund VIII coverage names EyeBio among Omega's recent success stories; EyeBio was bought by Merck & Co. for $1.3B (2024).
Source: fiercebiotech.com
Misses
Track record
Partners 3
- Claudio Nessi
Managing Director
Board seats
No public record - Francesco Draetta
Managing Director
Board seats
3 current
- Otello Stampacchia
Founder and Managing Director
Board seats
No public record
Reputation 3
No reputation score — basis not established for this firm.
- PitchBook — Omega Funds profile
pitchbook.com
- PrivateEquityList — Omega Funds profile
privateequitylist.com
- Fundraising Fox — Omega Funds thesis
fundraisingfox.com
Contact
Published sources only
Published contact
- Website
- omegafunds.net
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Omega Funds. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Grouped by disclosed AUM of $1.6B (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Omega Funds — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record · Reputation
- [2]
FIRM SITE · Omega Funds — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
